GK
Gowri Krishnamoorthy
About Gowri Krishnamoorthy
Data last updated:
Gowri Krishnamoorthy is a Director at Surien Pharmaceuticals Private Limited (since 2004), Director at Shince Pharmaceuticals Private Limited (since 2008) and Director at Sonivar Pharma Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma and Media and Publishing. The 2 current companies with reported revenue have a combined latest revenue of ₹18.57 Cr; the largest is Surien Pharmaceuticals Private Limited at ₹16.68 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Surien Pharmaceuticals Private Limited U24232TN2004PTC053031 | Director | 21 Apr 2004 | 2004 | ₹16.68 Cr (FY 2025) | Active |
| Shince Pharmaceuticals Private Limited U24232TN2008PTC069950 | Director | 24 Nov 2008 | 2008 | ₹1.89 Cr (FY 2025) | Active |
| Sonivar Pharma Private Limited U24230TN2023PTC158100 | Director | 06 Jan 2023 | 2023 | Active | |
| Chennai Jk Studio Technologies Private Limited U72900TN2016PTC112965 | Director | 18 Oct 2016 | 2016 | Active |
Board colleagues of Gowri Krishnamoorthy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chathurappan Anbazhagan | 08253456 | Surien Pharmaceuticals Private Limited | Whole-Time Director |
| Ramasamy Krishnamoorthy | 01651885 | Surien Pharmaceuticals Private Limited , Shince Pharmaceuticals Private Limited and 2 more | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gowri Krishnamoorthy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gowri Krishnamoorthy
Gowri Krishnamoorthy currently holds 4 directorships: Surien Pharmaceuticals Private Limited (Director, since 21 Apr 2004, revenue ₹16.68 Cr (FY 2025)); Shince Pharmaceuticals Private Limited (Director, since 24 Nov 2008, revenue ₹1.89 Cr (FY 2025)); Sonivar Pharma Private Limited (Director, since 06 Jan 2023); Chennai Jk Studio Technologies Private Limited (Director, since 18 Oct 2016).
Gowri Krishnamoorthy was first appointed on 21 Apr 2004 as Director at Surien Pharmaceuticals Private Limited. The most recent appointment on record is 06 Jan 2023 at Sonivar Pharma Private Limited.
The 2 current companies of Gowri Krishnamoorthy that report revenue have a combined latest revenue of ₹18.57 Cr: Surien Pharmaceuticals Private Limited ₹16.68 Cr (FY 2025); Shince Pharmaceuticals Private Limited ₹1.89 Cr (FY 2025).
The current boards of Gowri Krishnamoorthy's companies include Chathurappan Anbazhagan (Surien Pharmaceuticals Private Limited), Ramasamy Krishnamoorthy (Surien Pharmaceuticals Private Limited).